鄭 景泉

Medicine & Life Sciences

1. Chronic Renal Insufficiency 100%
2. Taiwan 77%
3. Coronavirus 51%
4. Clear-cell metastatic renal cell carcinoma 44%
5. Cinacalcet 41%
6. Mechanistic Target of Rapamycin Complex 1 39%
7. Kidney 39%
8. Acute Kidney Injury 38%
9. Population 38%
10. Vitamin D 38%
11. Temozolomide 33%
12. Cholecalciferol 31%
13. Angiotensin Receptor Antagonists 30%
14. Acidosis 28%
15. Drive 28%
16. Parathyroid Hormone 27%
17. Angiotensin-Converting Enzyme Inhibitors 26%
18. Glioblastoma 26%
19. Diabetes Mellitus 26%
20. DNA polymerase theta 26%
21. Histones 25%
22. corosolic acid 25%
23. Critical Illness 25%
24. Autophagy 25%
25. Human Influenza 25%
26. Renal Dialysis 24%
27. Secondary Hyperparathyroidism 24%
28. Multicenter Studies 23%
29. Cohort Studies 22%
30. Ions 22%
31. paricalcitol 22%
32. myo-inositol-1 (or 4)-monophosphatase 21%
33. Vaccination 21%
34. Down-Regulation 21%
35. CAP18 lipopolysaccharide-binding protein 21%
36. Autophagosomes 20%
37. Body Mass Index 19%
38. Off-Label Use 18%
39. Disease Progression 17%
40. Vascular Calcification 17%
41. Lactic Acidosis 17%
42. Up-Regulation 17%
43. Lactoferrin 17%
44. Renal Cell Carcinoma 17%
45. Triple Negative Breast Neoplasms 16%
46. Hip Fractures 16%
47. Calcitriol 15%
48. angiotensin converting enzyme 2 15%
49. Docetaxel 15%
50. Type C Phospholipases 15%